Inhibitory effect of Yunnan traditional medicines on hepatitis C viral polymerase

Journal of Natural Medicines

Volumn 60, Issue 3, 2006, Pages 217-224

  Jo, Michiko ^a   Nakamura, Norio ^a   Kakiuchi, Nobuko ^b   Komatsu, Katsuko ^a   Qui, Ming Hua ^c   Shimotohno, Kumiko ^d   Shimotohno, Kunitada ^e   Hattori, Masao ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c KUNMING INSTITUTE OF BOTANY   (China)

^d KEIO UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

Demethylzeylasteral; Hepatitis C virus; RNA dependent RNA polymerase; Tripterygium hypoglaucum; Yunnan crude drugs

Indexed keywords

ACORUS CALAMUS EXTRACT; ARTEMISIA ANNUA EXTRACT; BEGONIA EVANSIANA EXTRACT; CELASTROL; CERATOSTIGMA WILLMOTTIANUM EXTRACT; CLADONIA FALLAX EXTRACT; CROCUS SATIVUS EXTRACT; DEMETHYLZEYLASTERAL; EUCHEUMA GELATINAE EXTRACT; HEDYOTIS DIFFUSA EXTRACT; HEDYOTIS TENELLIFLORA EXTRACT; HUASHIDANCHA EXTRACT; MAYTENUS FOOKERII EXTRACT; PERIPLOCA CALOPHYLLA EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PLUMBAGO ZEYLANICA EXTRACT; POTENTILLA GRIFFITHII EXTRACT; RNA DIRECTED RNA POLYMERASE; RUMEX NEPALENSIS EXTRACT; SALVIA YUNNANENSIS EXTRACT; SCHISANDRA HENRYI EXTRACT; SMILAX FEROX EXTRACT; STROBILOMYCES FLOCCOPUS EXTRACT; TETRASTIGMA HYPOGLAUCUM EXTRACT; THALICTRUM GLANDULOSISSIMUN EXTRACT; TRIPTERYGIUM FORRESTII EXTRACT; TRIPTERYGIUM HYPOGLAUCUM EXTRACT; UNINDEXED DRUG; VERBENA OFFICINALIS EXTRACT;

ACORUS CALAMUS; ANTIVIRAL ACTIVITY; ARTICLE; BARK; BEGONIA EVANSIANA; CERATOSTIGMA WILLMOTTIANUM; CLADONIA FALLAX; CONTROLLED STUDY; DIRRHOSA CIRRHOSA; DRUG INHIBITION; DRUG ISOLATION; DRUG SCREENING; EUCHEUMA GELATINAE; FAGOPYRUM; FAGOPYRUM CYMOSUM; HEDYOTIS; HEDYOTIS DIFFUSA; HEDYOTIS TENELLIFLORA; HEPATITIS C VIRUS; HUASHIDANCHA; IC 50; KADSURA; KADSURA LONGIPEDUNCULATA; MAYTENUS; MAYTENUS FOOKERII; MEDICINAL PLANT; PERIPLOCA; PERIPLOCA CALOPHYLLA; PLANT LEAF; PLANT ROOT; PLUMBAGO ZEYLANICA; POTENTILLA; POTENTILLA GRIFFITHII; RUMEX; RUMEX NEPALENSIS; SALVIA; SALVIA YUNNANENSIS; SARGENTODOXA CUNEATA; SARSAPARILLA; SCHISANDRA HENRYI; SCHISANDRACEAE; SMILAX FEROX; STROBILOMYCES FLOCCOPUS; TETRASTIGMA HYPOGLAUCUM; THALICTRUM; THALICTRUM GLANDULOSISSIMUN; TRADITIONAL MEDICINE; TRIPTERYGIUM; TRIPTERYGIUM FORRESTII; TRIPTERYGIUM HYPOGLAUCUM;

EID: 42149167234     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-006-0041-7     Document Type: Article

References (28)

1. QL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton 1989 Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 359 362
2. L Pacini L Bartholomew A Vitelli G Migliaccio 2004 Reporter substrates for assessing the activity of the hepatitis C virus NS3-4A serine protease in living cells Anal Biochem 331 46 59
3. MJ Alter HS Margolis K Krawczynski FN Judson S Mares WJ Alexander PY Hu JK Miller MA Gerber RE Sampliner EL Meeks MJ Beach 1992 The natural history of community-acquired hepatitis C in the United States: the sentinel counties chronic non-A, non-B hepatitis study team N Engl J Med 327 1899 1905
4. C Niederau S Lange T Heintges A Erhardt M Buschkamp D Hurter M Nawrocki L Kruska F Hensel W Petry D Haussinger 1998 Prognosis of chronic hepatitis C: results of a large prospective cohort study Hepatology 28 1687 1695
5. I Saito T Miyamura A Ohbayashi H Harada T Katayama S Kikuchi Y Watanabe S Koi M Onji Y Ohta QL Choo M Houghton G Kuo 1990 Hepatitis C virus infection is associated with the development of hepatocellular carcinoma Proc Natl Acad Sci U S A 87 6547 6549
6. I Sarrazin U Mihm E Herrmann C Welsch M Albrecht U Sarrazin S Traver T Lengauer S Zeuzem 2005 Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection J Infect Dis 192 1710 1719
7. MP Walker TC Appleby W Zhong JY Lau Z Hong 2003 Hepatitis C virus therapies: current treatments, targets, and future perspectives Antivir Chem Chemother 14 1 21
8. R De Francesco L Tomei S Altamura V Summa G Migliaccio 2003 Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase Antiviral Res 58 1 16
9. No author listed 2005 Hepatitis C update: strategies for treatment, compliance, and long-term health Am J Manag Care 11 S284 S285
10. S Bressanelli L Tomei A Roussel I Incitti RL Vitale M Mathieu R De Francesco FA Rey 1999 Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus Proc Natl Acad Sci U S A 23 13034 13049
11. SE Behrens L Tomei R De Francesco 1996 Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus EMBO J 15 12 22
12. R De Francesco G Migliaccio 2005 Challenges and successes in developing new therapies for hepatitis C Nature 436 953 960
13. T Kimura M Jyo N Nakamura K Komatsu M Hattori K Shimotohono K Shimotohono N Kakiuchi 2003 Inhibitory effect of Tibetan medicinal plants on viral polymerases J Trad Med 20 243 250
14. Dictionary of Chinese Materia Medica (1998) Shanghai Science and Technology, China, Shogakukan, Tokyo
15. Pharmaceutical Company of Yunnan Province (1993) Yunnan Zhongyao Ziyuan Minglu (The Resource of Chinese Materia Medica in Yunnan). Science Press, Beijing, China
16. Jo M, Nakamura N, Kurokawa M, Komatsu K, Shiraki K, Hattori M (2005) Anti-herpes simplex virus activities of traditional Chinese medicines, used in Yunnan and Tibetan provinces of China. J Trad Med 22:321-328
17. T Yamashita S Kaneko Y Shirota WP Qin T Nomura K Kobayashi S Murakami 1998 RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region J Biol Chem 273 15479 15486
18. T Okuda K Mouri R Murakami 1977 Studies on constituents of Geranii Herba VI Yakugaku Zasshi 97 1273 1278
19. Gamlath CB, Gunaherath GMB, Gunatilaka AAL (1987) Studies on terpenoids and steroids. Part 10. Structures of four new natural phenolic D: A-friedo-24-noroleanane triterpenoids. J Chem Soc Perkin Trans I:2849-2854
20. T Morota CX Yang T Ogino WZ Qin T Katsuhara LH Xu Y Komatsu KL Miao M Maruno BH Yang 1995 D: A-Friedo-24-noroleanane from Tripterygium wilfordii Phytochemistry 39 1159 1163
21. H Duan K Kawazoe M Bando M Kido Y Takaishi 1997 Di- and tri-terpenoids from Tripterygium hypoglaucum Phytochemistry 46 535 543
22. JC Cyong SM Kim K Iijima T Kobayashi M Furuya 2000 Clinical and pharmacological studies on liver diseases treated with Kampo herbal medicine Am J Chin Med 28 351 360
23. H Duan Y Takaishi 1998 Structures of sesquiterpene polyol alkaloids from Tripterygium hypoglaucum Phytochemistry 49 2185 2189
24. R Fujita H Duan Y Takaishi 2000 Terpenoids from Tripterygium hypoglaucum Phytochemistry 53 715 722
25. WJ Zhuang CC Fong J Cao L Ao CH Leung HY Cheung PG Xiao WF Fong MS Yang 2004 Involvement of NF-κB and c-myc signaling pathways in the apoptosis of HL-60 cells induced by alkaloids of Tripterygium hypoglaucum (Levl.) Hutch Phytochemistry 11 295 302
26. 2+ channels and progesterone-induced sperm acrosome reaction Eur J Pharmacol 464 9 15
27. S Ushiro M Ono J Nakayama T Fujiwara Y Komatsu K Sugimachi M Kuwano 1997 New nortriterpenoid isolated from anti-rheumatoid arthritic plant, Tripterygium wilfordii, modulates tumor growth, and neovascularization Int J Cancer 72 657 663
28. T Mashino K Shimotohno N Ikegami D Nishikawa K Okuda K Takahashi S Nakamura M Mochizuki 2005 Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives Bioorg Med Chem Lett 15 1107 1109